News

This MS awareness month, Dr. Carolina Garcia, a neurologist at Saint Luke's Comprehensive Multiple Sclerosis Center, discusses diagnosing and treating this inflammatory and presumed autoimmune condition.

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

Growing research shows why popular GLP-1 weight loss medications might be beneficial for people with multiple sclerosis, but the jury’s still out.

Empower yourself by learning all you can about therapies for multiple sclerosis.

Jennifer Sonsiadek, Nurse Manager of Saint Luke’s Clinical Forensic Program, talks to KCTV about how Saint Luke’s has been leading the way and innovating clinical forensic care provided in Kansas City and the nation for 50 years.

The care a person receives immediately following abuse or assault has a significant effect on their physical, emotional, and psychological well-being.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

FOX4 talked to Dr. Karin Olds about Guillain-Barre Syndrome and recovery.

A recent study out of Harvard School of Public Health found a strong relationship between those who had mononucleosis, or the “kissing disease,” and multiple sclerosis later in life.

An expert with Saint Luke’s Comprehensive Multiple Sclerosis Center discusses early detection and exciting new advances in treatment.